RASSF1E inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of RASSF1E, one of the alternative spliced isoforms of the Ras Association Domain Family 1 (RASSF1) gene. The RASSF1 family plays a crucial role in regulating key cellular processes, including apoptosis, cell cycle control, and cytoskeletal organization. RASSF1 isoforms, such as RASSF1E, interact with Ras GTPases and other signaling molecules to influence these critical pathways. Each isoform, including RASSF1E, can perform distinct or overlapping functions in regulating cellular responses to various environmental cues, such as growth signals and stress. Inhibitors of RASSF1E typically function by interfering with its ability to bind to specific proteins or modulate signaling pathways, thereby disrupting its regulatory role in cell fate determination and homeostasis.
Inhibition of RASSF1E has significant implications for the cellular processes it regulates, particularly in the context of apoptosis and cell cycle regulation. By blocking RASSF1E's ability to participate in key protein-protein interactions, these inhibitors disrupt signaling pathways that control programmed cell death and cell growth, potentially leading to altered cellular behavior. Researchers utilize RASSF1E inhibitors to investigate the specific role of this isoform within the broader RASSF1 family, aiming to understand how alternative splicing contributes to the functional diversity of these proteins. These inhibitors also provide insights into how RASSF1E interacts with Ras-related pathways and contributes to maintaining cellular homeostasis. Studying RASSF1E inhibitors allows researchers to uncover the nuances of isoform-specific signaling, offering a deeper understanding of the molecular mechanisms that regulate apoptosis, cell cycle progression, and cytoskeletal dynamics. This research sheds light on the complex regulatory networks that maintain cellular stability and respond to external stimuli.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
May promote the demethylation of the RASSF1E promoter, potentially repressing its abnormal expression in cancer cells where it is otherwise hypermethylated. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
Could selectively demethylate the RASSF1E CpG island, leading to a suppression of its ectopic overexpression in tumor cells. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Might repress RASSF1E transcription through the enhancement of histone acetylation, leading to changes in chromatin structure around the gene locus. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
May specifically target histone deacetylase enzymes, leading to hyperacetylation of histones near the RASSF1E gene and consequent transcriptional silencing. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Could engage retinoic acid receptors to repress transcription factors essential for RASSF1E expression during cellular differentiation processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
May result in a decrease in RASSF1E transcription as a secondary effect of inhibiting mTOR signaling, which is known to control the translation of a broad array of genes. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Could bind to DNA at the transcription initiation complex and block the elongation phase of mRNA synthesis, leading to decreased RASSF1E mRNA levels. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
By inhibiting eukaryotic protein biosynthesis, it could non-specifically decrease the stability of transcription factors required for RASSF1E expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Might bind strongly to the GC-rich sequences of the RASSF1E promoter, displacing necessary transcription factors and thereby reducing gene transcription. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Could alter the endosomal and lysosomal pH balance, leading to impaired degradation of transcriptional regulators of RASSF1E, thereby decreasing its expression. | ||||||